Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Updated analysis incorporating new evidence

Simon van der Pol; Sajad Emamipour; Anita van Oudheusden; Bas Slierendregt; Gerald Moncayo; Cornelis Boersma

doi:10.1016/j.jvacx.2026.100857

Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Updated analysis incorporating new evidence

Simon van der Pol^*
, Sajad Emamipour
, Anita van Oudheusden
, Bas Slierendregt
, Gerald Moncayo
, Cornelis Boersma

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	100857
Number of pages	5
Journal	Vaccine: X
Volume	31
DOIs	https://doi.org/10.1016/j.jvacx.2026.100857
Publication status	Published - Aug 2026

Keywords

Cardiorespiratory hospitalizations
Cost-effectiveness analysis
High-dose inactivated influenza vaccination
Standard-dose inactivated influenza
Vaccination

Access to Document

10.1016/j.jvacx.2026.100857Licence: CC BY-NC-ND

Cite this

@article{88a0935f7d044e49b6ef9ec18a2791ae,

title = "Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Updated analysis incorporating new evidence",

keywords = "Cardiorespiratory hospitalizations, Cost-effectiveness analysis, High-dose inactivated influenza vaccination, Standard-dose inactivated influenza, Vaccination",

author = "\{van der Pol\}, Simon and Sajad Emamipour and \{van Oudheusden\}, Anita and Bas Slierendregt and Gerald Moncayo and Cornelis Boersma",

year = "2026",

month = aug,

doi = "10.1016/j.jvacx.2026.100857",

language = "English",

volume = "31",

journal = "Vaccine: X",

issn = "2590-1362",

publisher = "Elsevier",

}

TY - JOUR

T1 - Cost-effectiveness of high-dose influenza vaccination in the Netherlands

T2 - Updated analysis incorporating new evidence

AU - van der Pol, Simon

AU - Emamipour, Sajad

AU - van Oudheusden, Anita

AU - Slierendregt, Bas

AU - Moncayo, Gerald

AU - Boersma, Cornelis

PY - 2026/8

Y1 - 2026/8

KW - Cardiorespiratory hospitalizations

KW - Cost-effectiveness analysis

KW - High-dose inactivated influenza vaccination

KW - Standard-dose inactivated influenza

KW - Vaccination

U2 - 10.1016/j.jvacx.2026.100857

DO - 10.1016/j.jvacx.2026.100857

M3 - Article

SN - 2590-1362

VL - 31

JO - Vaccine: X

JF - Vaccine: X

M1 - 100857

ER -